Hepatitis G virus infection in liver transplant recipients

By Fischer L.   Sterneck M.   Feucht H.H.   Schuhmacher C.   Malago M.   Rogiers X.   Laufs R.   Broelsch C.E.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 496-499

Elsevier

Access to resources Recommend Favorite

Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant ''CMV at Risk'' Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid)

By Ahsan N.   Holman M.J.   Sonderbye L.   Langhoff E.   Yang H.C.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1383-1385

Elsevier

Access to resources Recommend Favorite

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

By Anglicheau D.   Lautrette A.   Scieux C.   Thervet E.   Martinez F.   Flamant M.   Morinet F.   Legendre C.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2826-2827

Elsevier

Access to resources Recommend Favorite

Clinical pattern, risk factors, and outcome of CMV infection in renal transplant recipients: local experience

By Yeung J.S.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3144-3145

Elsevier

Access to resources Recommend Favorite

Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients

By Yeung S.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1928-1929

Elsevier

Access to resources Recommend Favorite